ArticleBMC emergency medicine2026
Distinguishing myocarditis from perimyocardial syndromes in children presenting to the emergency department: a biomarker-based approach.
Article in BMC emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMyocarditis and perimyocardial syndromes share overlapping features but differ in management. Differentiating them in children presenting with chest pain or palpitations remains difficult, particularly in non-fulminant cases. This study evaluated the diagnostic value of inflammatory biomarkers, especially the Systemic Immune-Inflammation Index (SII), in distinguishing perimyocardial syndromes from isolated myocarditis in the pediatric emergency department (PED).
methodWe retrospectively analyzed patients aged 1-18 years diagnosed with myocarditis, perimyocardial syndromes, or acute pericarditis between 2015 and 2021. Clinical characteristics, laboratory, ECG and echo findings of all patients were recorded. SII was calculated using neutrophil, platelet, and lymphocyte counts obtained within six hours of PED admission. ROC analysis assessed diagnostic performance.
results166 eligible subjects were enrolled (74 cases of myocarditis, 63 cases of myopericarditis, 21 cases of perimyocarditis, and 8 cases of acute pericarditis). The median age was 15 (12-17) years, and 76.5% of the patients were male. The median WBC, ANC and SII were respectively 7.44 (IQR 6.22-9.32), 3.93 (IQR 3.38-5.00), and 418 (IQR 286-679) in the myocarditis and significantly lower than the other groups (p < 0.001). In estimation of perimyocardial syndromes, AUC was 0.735 for WBC, 0.805 for ANC, 0.803 for SII (p < 0.001). The optimal cut-off values determined by the Youden Index were 8.24(x109/L) for WBC, 4.85(x109/L) for ANC, and 693 for SII, with corresponding sensitivities of 67.4%, 76.1%, and 73.9%, and specificities of 61.6%, 67.1%, and 75.3%, respectively.
conclusionsSII and ANC are useful, accessible biomarkers for differentiating perimyocardial syndromes from myocarditis. Their integration into early diagnostic strategies may support efficient triage and decision-making in the PED.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.